Industry Conference

Phenomenex, a Danaher company, launches its Luna Omega HILIC columns, aiming to simplify complex analysis in pharma, food safety, and diagnostics.

Global outdoor brand BLACKYAK moves beyond declarations, taking its climate summit to the Himalayan frontlines to launch a concrete action plan with local communities.

A Chinese medical device company just won top honors from global investors. It's not just a trophy—it's a masterclass in corporate strategy and global ambition.

Minister Joly's high-stakes meetings in Montreal aim to forge a resilient industrial and economic partnership with Europe, moving beyond trade to secure value.

A new data-driven index is flipping the script on what makes a festival great, and the results are surprising. Here's why Europe is winning the culture war.

With its new biomimetic DexHand and massive funding, TARS isn't just building a robot hand. It's aiming to bridge the gap between AI and the physical world.

With its new SmartBioSurface slides, Italian firm Tethis aims to solve a major lab challenge. The key? A nanotech surface that could reshape disease research.

South Korea's Dong Bang Co Ltd is moving beyond commodity animal drugs, targeting high-barrier markets. Is its focus on proprietary tech a viable global strategy?

At a key industry summit, Camel Energy unveiled a dual battery strategy for Europe, pairing advanced lithium-ion with disruptive sodium-ion technology.

At Shanghai's CHINA CYCLE expo, CST Tires unveiled more than just lightweight tech; it showcased a strategic pivot that could redefine global manufacturing.

Digital health firm Osara Health is targeting the 'Cancer Care Cliff,' backing its new survivorship program with a validated 25:1 ROI and proven health outcomes.

Zealand Pharma's petrelintide shows double-digit weight loss with remarkably few side effects, positioning it to challenge GLP-1 giants in the $100B market.

Fifteen high schoolers, mentored by racing icons, turned a Harley Nightster into a track-ready beast, proving the power of hands-on technical education.

DBV Technologies heads to a key investor conference with its VIASKIN patch for peanut allergies. Can its science and strategy convince Wall Street?

The Ontario Science Centre's event with astronaut Jeremy Hansen is more than a celebration; it's a strategic play for relevance and a national talent drive.

With record profits and a booming backlog, M-tron Industries is pitching its critical role in national security to top investors. Here's why they're listening.

A new open standard called Aliro, backed by industry giants, is set to revolutionize access control, promising a future free from proprietary walled gardens.

A small biotech just unveiled data for an oral weight-loss pill that appears twice as effective as a key competitor in early tests, shaking up the market.

A breakthrough biomarker, DNlite™, analyzes landmark trial data, offering a new way to identify high-risk diabetes patients missed by current standards.

As Canada prepares for Pride Season, a new federal funding announcement for security highlights a stark reality: celebration now requires fortification.